Acute Myeloid Leukemia: A Concise Review - Wikidata - awgldk - TriplyDB

Acute Myeloid Leukemia: A Concise Review

Acute Myeloid Leukemia: A Concise Review

http://www.wikidata.org/entity/Q26766719

about

Novel therapeutic options in Acute Myeloid Leukemia Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia Chromosome t(7;11)(p15;p15) translocation in acute myeloid leukemia coexisting with multilineage dyspoiesis and mutations in NRAS and WT1: A case report and literature review Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition Upregulation of Leukocytic Syncytin-1 in Acute Myeloid Leukemia Patients.Ikaros expression sensitizes leukemic cells to the chemotherapeutic drug doxorubicin Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.Inhibition of MicroRNA-149-5p Induces Apoptosis of Acute Myeloid Leukemia Cell Line THP-1 by Targeting Fas Ligand (FASLG).The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.Acute myeloid leukaemia genomics.Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis.Cordycepin induces apoptosis of human acute monocytic leukemia cells via downregulation of the ERK/Akt signaling pathway.MiR-302a sensitizes leukemia cells to etoposide by targeting Rad52.Single-cell whole exome and targeted sequencing in NPM1/FLT3 positive pediatric acute myeloid leukemia.Extracellular NME proteins: a player or a bystander?Population Pharmacokinetics of Volasertib Administered in Patients with Acute Myeloid Leukaemia as a Single Agent or in Combination with Cytarabine.Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia.Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlation.Developing and piloting an instrument to prioritize the worries of patients with acute myeloid leukemia.Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy.Expression levels of the runt-related transcription factor 1 and 3 genes in the development of acute myeloid leukemia.Analysis of Candidate Idarubicin Drug Resistance Genes in MOLT-3 Cells Using Exome Nuclear DNA Targeting dihydroorotate dehydrogenase in acute myeloid leukemia

P2860

Q28069889-AB9DAF66-9369-4545-B428-A04343E4839E Q28075654-D4C7F28D-99DF-4C60-8C46-6E673B91F1AB Q33684901-CAD5DF4D-8F1C-495C-AD17-544393E7510E Q33761979-9E60E62E-0969-42D5-8F59-3304BBEEE488 Q37087664-7327A08F-4954-4488-8BB8-7CD823AFEDB0 Q37106766-116D074C-B703-49BA-BF29-299487338BDB Q37702629-24755AD7-FCBA-409B-B7D6-595E2AA2F83F Q38660073-141C1FF4-47AA-42A8-9155-39445E24ED80 Q38724417-556B9F6D-126B-4A75-8F43-17798DAB1336 Q38739798-8434B69D-2B88-4135-9545-AAC10BDBA2C8 Q39400164-F50F303D-E82C-448B-919B-84FC5C742DD2 Q41530049-8EF80C83-D6A3-4BF7-A68E-95227D636FE2 Q41623491-52269095-A1CD-4033-96DB-69E262DB221A Q47142346-A778C39A-A0BF-40AF-A89E-DCCE9AC4C684 Q47579484-6B536FE9-91A9-4447-BADF-B0616C50D3F8 Q47648708-B46998D8-EEEF-41FD-B44F-5D80906F1833 Q48253128-007E7A14-063F-4A0D-B8DC-69162EB06FD5 Q52608845-DBAA45CD-7A83-4548-B053-47D3F11B9159 Q53465288-073DB794-FCBF-4450-AA74-9EF82B032F35 Q54958123-8C9D483D-4523-4885-A1E1-DBADBF4F33A1 Q55090588-9C22EEEB-6975-4780-B663-6FD3A17745E6 Q55355645-4024AECD-8808-4F1C-AFCE-12B2055275E5 Q57753502-663D27DE-1197-4AB1-9D76-CE84FA8D936C Q58776972-7D53EB7A-AAA3-4B38-86CC-6061876AEF29

P2860

Acute Myeloid Leukemia: A Concise Review

http://www.wikidata.org/entity/Q26766719

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Acute Myeloid Leukemia: A Concise Review

@ast

Acute Myeloid Leukemia: A Concise Review

@en

Acute Myeloid Leukemia: A Concise Review

@nl

type

label

Acute Myeloid Leukemia: A Concise Review

@ast

Acute Myeloid Leukemia: A Concise Review

@en

Acute Myeloid Leukemia: A Concise Review

@nl

prefLabel

Acute Myeloid Leukemia: A Concise Review

@ast

Acute Myeloid Leukemia: A Concise Review

@en

Acute Myeloid Leukemia: A Concise Review

@nl

P1433

Q26766719-332CAAC1-F410-412B-B0DC-69C836338004

P1476

Q26766719-92D0A21C-E9E6-46E0-98E6-100AA9A7C419

P2093

Q26766719-7A0AFE6D-6646-4253-B90B-3F800C20C4DA

Q26766719-DE08324E-65F0-48C7-972F-7B7EDF71E2F3

P2860

Q26766719-04C4363E-C857-447D-9C00-4F0E256383FF

Q26766719-067B5F09-AFC8-49B1-8FC8-9BAF4B6380E2

Q26766719-09942523-9CE5-4A18-868B-9ABB1495C088

Q26766719-09EAA614-0A19-4C39-A9B1-C08DFD8F5F7C

Q26766719-0BE1073C-8D5F-4C46-943C-B3D40D199AFD

Q26766719-0D223690-DAFF-475D-8979-3D48359E791D

Q26766719-0E16AA4C-73EA-4C04-AC37-0FD659B421F1

Q26766719-11A7DF2A-190A-4BAE-9854-3D152527B5E7

Q26766719-14BF3EE4-A4E1-4C51-AD68-A49C3779D1DC

Q26766719-1DDA1F8E-7741-420E-B6D5-177716128DBB

P304

Q26766719-08DC75F5-26F0-4871-8A2E-31A4AB2B7C90

P31

Q26766719-F59CC26C-4193-4394-BDAA-E736661F4379

P356

Q26766719-AD7E8973-D1D9-4431-8F17-D2B7DBF09D1B

P407

Q26766719-F428911E-0F96-4889-AE32-30D37D467397

P433

Q26766719-C7E02BAC-BCEA-44FB-B6A5-11FB72461ABD

P478

Q26766719-57230E77-DBA4-4FEB-8825-7B15AA1FB566

P577

Q26766719-B61C5979-602C-4D96-846A-BFED3EC163FC

P5875

Q26766719-5F0E063B-A42B-426C-A217-DCD7ADFFA108

P698

Q26766719-82AD61AC-E8B9-4A95-9C27-9F4018396B09

P921

Q26766719-D20AE21D-5D0D-456B-BC3A-7CAF6501F108

P932

Q26766719-19256999-5C3E-4430-AB7A-097C9BA3E056

P356

P1433

Journal of Clinical Medicine

P1476

Acute Myeloid Leukemia: A Concise Review

@en

P2093

Jennifer N Saultz

http://www.w3.org/2001/XMLSchema#string

Ramiro Garzon

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?

DNMT3A Mutations in Acute Myeloid Leukemia

Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

P304

33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/JCM5030033

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297657924

http://www.w3.org/2001/XMLSchema#string

P698

26959069

http://www.w3.org/2001/XMLSchema#string

P921

P932

4810104

http://www.w3.org/2001/XMLSchema#string